Breaking News Bar

Business News and Information

Inovio stock plunges more than 34% as FDA puts Covid-19 vaccine trial on hold

The FDA wants the Plymouth Meeting company to answers some questions before it can move forward with late-stage testing of the experimental vaccine.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear